Prosperity Consulting Group’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,966
Closed -$202K 308
2024
Q1
$202K Buy
+2,966
New +$202K 0.03% 317